Comparison Between Intrathecal and Intravenous Dexmedetomidine
Comparison Study Between Intrathecal and Intravenous Dexmedetomidine in Lower Limb Surgeries
研究概览
详细说明
Seventy patients undergoing lower limb surgeries were included in this study. Using a random number sequence, patients were enrolled in one of two groups: Group T receiving 5 µg of dexmedetomidine (Precedex® 100 µg/mL, Hospira, Inc., IL, U.S.A.) combined with 12.5 mg of 0.5% hyperbaric bupivacaine (Marcaine® Spinal Heavy; Astra, Sodertalje, Sweden) and Group V receiving the same bupivacaine DOSE AND 0.75 microgram/kilogram of body weight dexmedetomidine intravenously. Dexmedetomidine 100 µg/mL was mixed with preservative-free normal saline to 10 µg/mL. The 0.5 mL of dilute dexmedetomidine was added to the bupivacaine in group T. An independent investigator prepared the drug solutions and provided the coded drug to the anaesthetic administrator before the start of the anaesthesia. The anaesthetic administrator, patients, outcome assessors, and data analysts were blinded to the allocation. Spinal Anesthesia Patients were hydrated with 500 mL of 0.9% sodium chloride solution before anaesthesia. The spinal puncture was performed at L3-4 or L4-5 with a midline approach using a 25 G Quincke needle in the lateral decubitus position. After confirmation of free flow and clear cerebrospinal fluid, the drug was administered and the patients were then placed in the supine neutral position.
Assessment: The primary end-point of this study was the first request to analgesia. The secondary end-points were the total postoperative analgesic consumption as well as the VAS.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
Ismailia、埃及
- Suez Canal University
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- ASA I-II patients
- age 18-65 years
- scheduled for lower limb surgery
- spinal anaesthesia
Exclusion Criteria:
- patients with coagulopathy
- infection at the site of lumbar puncture
- beta-blockers or calcium channel blockers usage
- hypersensitivity to Bupivacaine or Dexmedetomidine
- any other contra-indications for spinal anaesthesia.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:交叉作业
- 屏蔽:四人间
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:IT intrathecal
administration of intrathecal dexmedetomidine in addition to bupivacaine for lower limb surgeries
|
INTRATHECAL AND INTRAVENOUS
其他名称:
|
|
有源比较器:IV intravenous
administration of intravenous dexmedetomidine in addition to spinal anaesthesia for lower limb surgeries
|
INTRATHECAL AND INTRAVENOUS
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
First request to analgesia
大体时间:Postoperative up to 24 hours
|
The first time the patient is asking for analgesia to control his pain
|
Postoperative up to 24 hours
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Total postoperative analgesia consumption
大体时间:Postoperative up to 24 hours
|
Total consumption of analgesia to control pain
|
Postoperative up to 24 hours
|
|
visual analogue scale
大体时间:Every two hours for 24 hours postoperative
|
The score subjectively measures the severity of pain and it is ranging from 0 when there is no pain to 10 when it is the worse pain imaginable
|
Every two hours for 24 hours postoperative
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.